Stevanato Group S.p.A.

Stevanato Group designs and manufactures products and processes for the biopharmaceutical and diagnostic industries. The company's primary offerings include drug containment solutions such as pre-fillable syringes, cartridges, vials, and ampoules, alongside drug delivery systems including pen injectors, auto-injectors, and wearable injectors. It also produces in-vitro diagnostic solutions, diagnostic laboratory consumables, and pharmaceutical visual inspection machines, along with assembling, packaging, and glass-forming equipment used in manufacturing workflows.

The company operates through two segments: Biopharmaceutical and Diagnostic Solutions, which encompasses drug containment, delivery systems, and diagnostic products; and Engineering, which focuses on manufacturing machinery and equipment. Additionally, Stevanato provides contract development and manufacturing services for customer-owned drug delivery devices, as well as analytical and regulatory support services. After-sales offerings include spare parts and maintenance services.

Stevanato serves pharmaceutical, biotechnology, diagnostics, and life sciences companies globally, including drug product manufacturers and fill-and-finish contract manufacturers. Headquartered in Piombino Dese, Italy, the company employs 5,521 full-time staff and maintains operations across Europe, the Middle East, Africa, North America, South America, and the Asia Pacific region. The company was founded in 1949 and operates as a subsidiary of Stevanato Holding S.R.L.